Why the study?
Does levosimendan improve haemodynamics and myocardial substrate utilization in low-risk patients early after coronary artery bypass grafting?
Does levosimendan improve haemodynamics and myocardial substrate utilization in low-risk patients early after coronary artery bypass grafting?
Levosimendan improves cardiac output and decreases vascular resistance without increasing myocardial oxygen consumption in patients after CABG.
No takes yet. Share an insight, caveat, or question.
Supports levosimendan for post-CABG hemodynamic support without raising myocardial oxygen consumption; extends prior data to the early postoperative period.
Jyrki Lilleberg (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: